Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids
Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids
The objective of this study is to compare healthcare utilization and costs in asthma patients
 who receive fluticasone propionate/salmeterol combination 100mcg/50mcg ("FSC 100/50") or
 inhaled corticosteriods in typical clinical practice using a retrospective observational
 cohort study design of large managed care database.
Inclusion Criteria:

 -  Subjects with asthma as determined by ICD-9 codes and asthma drug use

 -  at least 12 years of age

 -  treated with inhaled corticosteroids

 Exclusion Criteria:

 -  Subjects with COPD or treatment for COPD